Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RAVI KUMAR PATEL

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1841633286
CMS profile
2790159
Location
STUART, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$4,871.55

222 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $4,192.12 213
Education $679.43 9

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Janssen Biotech, Inc. $598.00 22
Astellas Pharma US Inc $429.20 9
AstraZeneca Pharmaceuticals LP $337.47 18
Novartis Pharmaceuticals Corporation $265.61 14
Lilly USA, LLC $262.88 10
PFIZER INC. $215.82 17
GlaxoSmithKline, LLC. $207.03 10
GENZYME CORPORATION $202.41 9
Celgene Corporation $173.39 13
Amgen Inc. $168.24 11
Regeneron Healthcare Solutions, Inc. $159.77 4
Seagen Inc. $139.11 8
Pharmacyclics LLC, An AbbVie Company $139.01 7
Incyte Corporation $118.84 5
Genentech USA, Inc. $110.12 4
Mirati Therapeutics, Inc. $108.99 5
Jazz Pharmaceuticals Inc. $98.55 5
Merck Sharp & Dohme LLC $98.46 5
Daiichi Sankyo Inc. $93.89 4
E.R. Squibb & Sons, L.L.C. $76.23 4
Sun Pharmaceutical Industries Inc. $75.78 1
Ipsen Biopharmaceuticals, Inc $68.43 3
ARRAY BIOPHARMA INC $61.17 3
TerSera Therapeutics LLC $55.67 2
Eisai Inc. $44.58 2
Karyopharm Therapeutics Inc. $44.10 2
Coherus Biosciences Inc. $38.74 2
ABBVIE INC. $36.95 2
Alexion Pharmaceuticals, Inc. $32.23 2
Tolmar, Inc. $29.92 1
PharmaEssentia USA Corporation $27.02 1
Sumitomo Pharma America, Inc. $26.81 1
Deciphera Pharmaceuticals Inc. $24.98 1
SERVIER PHARMACEUTICALS LLC $23.18 1
Foundation Medicine, Inc. $23.13 1
Mylan Institutional Inc. $23.12 1
CTI BioPharma Corp. $22.21 1
Takeda Pharmaceuticals U.S.A., Inc. $21.75 1
Exelixis Inc. $21.37 1
Bayer Healthcare Pharmaceuticals Inc. $20.94 1
Blueprint Medicines Corporation $20.62 1
Agios Pharmaceuticals, Inc. $19.90 1
G1 Therapeutics, Inc. $19.61 1
Amneal Pharmaceuticals LLC $19.26 1
Rigel Pharmaceuticals, Inc. $18.75 1
Stemline Therapeutics Inc. $17.25 1
Pharmacosmos Therapeutics Inc. $16.18 1
ImmunoGen, Inc. $14.88 1

Page 3 of 5; records 101–150 of 222 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RAVI KUMAR PATEL

NPI 1841633286 · CMS profile ID 2790159

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

STUART, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 5; records 101–150 of 222 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1841633286?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RAVI KUMAR PATEL, NPI 1841633286, CMS profile ID 2790159. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 222 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1841633286?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). RAVI KUMAR PATEL, NPI 1841633286, CMS profile ID 2790159. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 5; records 101–150 of 222 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1841633286?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
RAVI KUMAR PATEL, NPI 1841633286, CMS profile ID 2790159, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 5; records 101–150 of 222 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1841633286?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

222 matching records · $4,871.55 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 222 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 222.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $24.4107/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011499227 CMS
PFIZER INC. $22.4207/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049214573 CMS
Janssen Biotech, Inc. $17.1207/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988677569 CMS
AstraZeneca Pharmaceuticals LP $19.9607/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011577971 CMS
Pharmacyclics LLC, An AbbVie Company $26.6307/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998292701 CMS
Amneal Pharmaceuticals LLC $19.2607/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053523849 CMS
Ipsen Biopharmaceuticals, Inc $22.3907/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1045454837 CMS
Foundation Medicine, Inc. $23.1307/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058792221 CMS
GENZYME CORPORATION $26.7107/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050133945 CMS
PFIZER INC. $13.8007/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050490691 CMS
Eisai Inc. $24.9806/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023328749 CMS
Seagen Inc. $19.5206/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995788169 CMS
Genentech USA, Inc. $29.6206/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040515907 CMS
GENZYME CORPORATION $17.2206/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050133957 CMS
Astellas Pharma US Inc $12.0506/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034188437 CMS
Novartis Pharmaceuticals Corporation $5.0806/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992772683 CMS
Celgene Corporation $1.0606/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014691301 CMS
Celgene Corporation $0.4306/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014691313 CMS
Celgene Corporation $18.2606/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014691325 CMS
Janssen Biotech, Inc. $3.1106/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988677585 CMS
Janssen Biotech, Inc. $12.8306/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988677587 CMS
GENZYME CORPORATION $23.4106/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050133941 CMS
AstraZeneca Pharmaceuticals LP $17.4906/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011510707 CMS
Janssen Biotech, Inc. $22.3906/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988677583 CMS
PFIZER INC. $7.6306/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050460051 CMS
Lilly USA, LLC $23.0406/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032024061 CMS
Astellas Pharma US Inc $20.1806/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034142901 CMS
GlaxoSmithKline, LLC. $29.3406/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001710701 CMS
Lilly USA, LLC $1.1306/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1032010137 CMS
Novartis Pharmaceuticals Corporation $24.4306/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992772679 CMS
AstraZeneca Pharmaceuticals LP $18.9706/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011429223 CMS
Celgene Corporation $1.4106/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014691275 CMS
Celgene Corporation $19.2406/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014691287 CMS
Incyte Corporation $29.0106/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044456195 CMS
Janssen Biotech, Inc. $18.0105/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988677581 CMS
ABBVIE INC. $17.8205/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998093955 CMS
TerSera Therapeutics LLC $32.5805/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052422819 CMS
Celgene Corporation $29.4805/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014691263 CMS
Daiichi Sankyo Inc. $24.9105/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006419569 CMS
Agios Pharmaceuticals, Inc. $19.9005/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056213399 CMS
Mylan Institutional Inc. $23.1205/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1039007657 CMS
Janssen Biotech, Inc. $25.5805/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988677589 CMS
Jazz Pharmaceuticals Inc. $26.7205/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059083441 CMS
Mirati Therapeutics, Inc. $23.0005/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057999933 CMS
Mirati Therapeutics, Inc. $21.0005/09/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057999935 CMS
Stemline Therapeutics Inc. $17.2505/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040036283 CMS
Regeneron Healthcare Solutions, Inc. $2.2305/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999355325 CMS
Regeneron Healthcare Solutions, Inc. $17.7905/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999355331 CMS
SERVIER PHARMACEUTICALS LLC $23.1805/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055092609 CMS
AstraZeneca Pharmaceuticals LP $19.2704/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015103247 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $730.09 7
PY2020 $814.05 32
PY2021 $2,911.83 148
PY2022 $8,091.57 202
PY2023 $4,871.55 222
PY2024 $4,759.61 215
PY2025 $4,721.43 209

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $6,488.00 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Amgen Inc. $3,450.00 09/26/2025 Non-covered Recipient Entity
CBCC GLOBAL RESEARCH, INC. AT COMPREHENSIVE BLOOD AND CANCER CENTER
A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 193 in Combination With Other Therapies in Subjects With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous MTAP-deletion No dispute reported 06/30/2026 1246640097
Principal investigator 1 PFIZER INC. $1,519.00 09/02/2025 Non-covered Recipient Entity
TRANSLATIONAL RESEARCH IN ONCOLOGY
A RANDOMIZED PHASE 3 OPENLABEL STUDY TO EVALUATE SGNB6A COMPARED WITH DOCETAXEL IN ADULT SUBJECTS WITH PREVIOUSLY TREATED NONSMALL CELL LUNG CANCER No dispute reported 06/30/2026 1228719947
Principal investigator 1 PFIZER INC. $1,519.00 02/24/2025 Non-covered Recipient Entity
TRANSLATIONAL RESEARCH IN ONCOLOGY
A RANDOMIZED PHASE 3 OPENLABEL STUDY TO EVALUATE SGNB6A COMPARED WITH DOCETAXEL IN ADULT SUBJECTS WITH PREVIOUSLY TREATED NONSMALL CELL LUNG CANCER No dispute reported 06/30/2026 1228780529